Trial Details

COMPLETED
Basic Information
Clinical ID c1250
Identifier NCT02536404
Trial Title Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Etrasimod|DRUG: Placebo
Participant Information
Sponsor Arena Pharmaceuticals
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2016-01-25
Primary Completion Date 2018-11-01
Completion Date 2018-11-01